Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,717.00
Bid: 1,712.00
Ask: 1,714.00
Change: 19.00 (1.12%)
Spread: 2.00 (0.117%)
Open: 1,699.00
High: 1,717.00
Low: 1,699.00
Prev. Close: 1,698.00
SMIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

21 May 2015 07:00

RNS Number : 8338N
Smiths Group PLC
21 May 2015
 

 

News Release

London, 21 May 2015

For immediate release

 

 

SMITHS GROUP PLC TRADING STATEMENT

 

Expectations for the year remain in line with the outlook presented at the interim results. In the nine months to 2 May 2015, underlying revenue and headline operating profit for the Group fell slightly against the prior year. This reflects continued like-for-like revenue growth in Smiths Medical and Flex-Tek offset by declines in Smiths Detection, Smiths Interconnect and John Crane. Headline operating cash conversion was strong at 96% for the year to date.

 

Underlying trading at John Crane in the first nine months was slightly below the equivalent period last year as a result of difficult market conditions in some parts of the energy segment. Overall aftermarket revenues grew driven by continued demand from mid and downstream customers, despite further declines from our small upstream artificial lift business. Sales to first-fit rotating equipment customers also fell in line with our expectations. The deterioration in third quarter trading conditions resulted in a mid-single digit decline in John Crane revenue for the quarter. At constant currencies, full year revenues are expected to decline modestly. However, cost saving initiatives and favourable product mix should support operating profit margins.

 

Smiths Medical continued to deliver underlying revenue growth in the third quarter although, as expected, the growth rate has slowed. Underlying revenue growth in the first nine months of the year has been driven by strong demand for ambulatory infusion pumps while the vital care and safety device franchises have shown smaller gains driven by general anaesthesia and sharps safety products respectively. Headline operating profit continued to benefit from higher volumes and cost saving initiatives despite an increased headwind from transactional foreign exchange. We expect continued revenue growth in the full year results, although the growth rate will be slower than the first half.

 

Smiths Detection delivered underlying growth in headline operating profit in both the third quarter and year to date against a weak comparator that was affected by £12m of non-recurring charges. Despite challenging trading conditions across many markets, which resulted in lower underlying revenue for the year to date, we continue to make good progress in implementing business improvement and cost cutting initiatives. These are contributing to an improved outlook for headline operating profit margin this year and strengthening our competitive positioning. As previously guided, full year revenue is expected to be below last year. Headline operating margins are likely to improve for the year against a comparator affected by one-off costs. The order book for delivery in FY16, coupled with the benefit of our cost savings, points to an improved performance in next financial year.

 

Smiths Interconnect continued to face challenging trading conditions. Underlying revenue fell in the quarter, following the year to date trend, due to ongoing delays in customer spending in wireless telecoms, programme slowdowns and further softness in several markets served by Connectors and Microwave, such as defence and medical. The decline was slightly offset by growth in data centres. While we expect some improvement in trading in the fourth quarter compared with the first nine months, full year revenue and headline operating profit will remain below prior year levels.

 

Flex-Tek reported a sustained improvement in underlying revenue and headline operating profit. Revenue growth was driven by continued progress in Heat Solutions and Construction revenues offsetting some weakness in Flexible Solutions. The outlook for the full year remains positive and in line with previous guidance.

 

At 2 May, net debt was £915m, slightly reduced from the £929m at 31 January 2015.

 

ENDS

 

This press release contains certain forward-looking statements with respect to the operations, performance and financial condition of the Group. By their nature, these statements involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. The forward-looking statements reflect knowledge and information available at the date of preparation of the press release and the Company undertakes no obligation to update these forward-looking statements. Nothing in this press release should be construed as a profit forecast.

 

 

Investor Relations

Peter Durman: +44 (0)20 7808 5535

 

Media Relations

Colin McSeveny: +44 (0)20 7808 5534

Anthony Cardew - Cardew Group: +44 (0)20 7930 0777

 

Smiths Group

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Our products and services make the world safer, healthier and more productive. Smiths Group employs around 23,000 people in over 50 countries. For more information visit www.smiths.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSEMFISFISEDI
Date   Source Headline
20th Jun 20247:00 amRNSTransaction in Own Shares
19th Jun 20247:00 amRNSTransaction in Own Shares
18th Jun 20247:00 amRNSTransaction in Own Shares
17th Jun 20247:00 amRNSTransaction in Own Shares
14th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSTransaction in Own Shares
7th Jun 20247:00 amRNSTransaction in Own Shares
6th Jun 20247:00 amRNSTransaction in Own Shares
5th Jun 20247:00 amRNSTransaction in Own Shares
4th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20243:35 pmRNSTotal Voting Rights
3rd Jun 202410:00 amRNSDirectorate Change
3rd Jun 20247:00 amRNSTransaction in Own Shares
31st May 20247:00 amRNSTransaction in Own Shares
21st May 20247:00 amRNSSmiths Group 3rd Quarter Results
16th May 20249:30 amRNSDirector/PDMR Shareholding
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20244:45 pmRNSDirector/PDMR Shareholding
1st May 20243:30 pmRNSTotal Voting Rights
1st May 202410:00 amRNSBlock listing Interim Review
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20249:00 amRNSDirector/PDMR Shareholding
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20244:30 pmRNSTotal Voting Rights
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:15 amRNSShare buyback programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.